表紙
市場調査レポート

POC診断 (ポイントオブケア診断) の世界市場:2015〜2019年

Global POC Diagnostics Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 325006
出版日 ページ情報 英文 104 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
POC診断 (ポイントオブケア診断) の世界市場:2015〜2019年 Global POC Diagnostics Market 2015-2019
出版日: 2015年02月25日 ページ情報: 英文 104 Pages
概要

POC (Point of Care:ポイントオブケア) 診断とは、臨床試験室以外の環境下で、患者が罹っている疾患を診断するために使用される、体外診断 (IVD) 用装置・ツールのことを指します。そうした装置を使って、患者の症状を迅速に診断し、適切な治療や薬剤を提供することができます。POC診断はコスト効率的で使いやすく、また診断中のミスの発生を押さえるために標準化されています。生活慣習病 (糖尿病、肥満症、心疾患など) や感染症の有病者数が増加してきたことから、POC診断の使用頻度は非常に高くなってきました。POC診断はまた、臨床診断の様々な分野 (血糖値検査や血液凝固検査、感染症検査、心臓マーカー診断、妊娠・受胎能検査、血中ガス/電解質検査、腫瘍マーカー検査、尿検査、コレステロール検査など) で使用されるようにもなっています。世界のPOC診断市場は、2014〜2019年にかけて、8.47%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、全世界のポイントオブケア診断 (POC診断) 市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • 米国のPOC診断市場
  • 欧州のPOC診断市場
  • ファイブフォース分析

第7章 用途別の市場区分

  • 世界の血液糖検査市場
  • 世界の感染症検査市場
  • 世界の心臓マーカー試験市場
  • 世界の凝固検査市場
  • 世界の妊娠・受胎能検査市場
  • 世界の血液ガス/電解質検査市場
  • 世界の腫瘍マーカー検査市場
  • 世界の尿検査市場
  • 世界のコレステロール検査市場

第8章 地域区分

  • 南北アメリカのPOC診断市場
  • 欧州・中東・アフリカ地域 (EMEA) のPOC診断市場
  • アジア太平洋地域のPOC診断市場

第9章 購入基準

第10章 市場成長促進要因

第11章 成長促進要因とその影響

第12章 市場の課題

第13章 成長促進要因と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • 企業合併・買収 (M&A)
  • ベンダー分析
  • その他の有力ベンダー

第17章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 部門別の市場収益額
    • 部門別の市場収益額 (過去の実績値)
    • 地域別の市場収益額
    • 事業戦略
    • 主要情報
    • SWOT分析
  • Alere
  • Bayer HealthCare
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson

第18章 関連レポート

図表一覧

目次
Product Code: IRTNTR5374

About POC Diagnostics

POC diagnostics are IVD devices and tools used for diagnosing diseases in patients outside a clinical laboratory setting. The use of these devices helps in the rapid diagnosis of the medical conditions and aids in providing appropriate treatments and medication to patients. They are cost-effective, user-friendly, and standardized to minimize errors during diagnosis. They are being used extensively for diagnostic purposes owing to the high prevalence of lifestyle diseases such as diabetes and obesity, cardiac disorders, and infectious diseases. They have a wide range of applications in clinical diagnosis such as the testing of blood glucose and coagulation, infectious diseases, cardiac markers, pregnancy and fertility, blood gas/electrolytes, tumor markers, urinalysis, and cholesterol.

TechNavio's analysts forecast the Global POC Diagnostics market to grow at a CAGR of 8.47 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global POC Diagnostics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC diagnostics used in various applications:

  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Coagulation testing
  • Pregnancy and fertility testing
  • Blood gas/electrolytes testing
  • Tumor markers testing
  • Urinalysis testing
  • Cholesterol testing

TechNavio's report, the Global POC Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Alere
  • Bayer Healthcare
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson

Other Prominent Vendors

  • A. Menarini Diagnostics
  • Abaxis
  • Acon
  • BD
  • Bio-Rad Laboratories
  • Chembio Diagnostics
  • Chongqing Haray International Business
  • Clarity Diagnostics
  • Clinical Innovations
  • Contec Medical
  • Eurotrol
  • Fudakang Ind'l
  • Helena Laboratories
  • i-sens
  • International Technidyne
  • Medtronic
  • Nipro Diagnostics
  • Nova Biomedical
  • OraSure Technologies
  • Phamatech
  • Quidel
  • Radiometer Medical
  • Randox Laboratories
  • SA Scientific
  • Sekisui Diagnostics
  • Shenzhen Fitconn Technology
  • Siemens Healthcare
  • STAT Technologies
  • Streck
  • TaiDoc
  • Trinity Biotech
  • Urit Medical

Market Driver

  • High Prevalence of Diabetes and Obesity
  • For a full, detailed list, view our report

Market Challenge

  • Limitation of POC Diagnostics
  • For a full, detailed list, view our report

Market Trend

  • Rapid Adoption of POC Diagnostic Tests
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. POC Diagnostics Market in US
    • 06.3.1. Market Size and Forecast
  • 06.4. POC Diagnostics Market in Europe
    • 06.4.1. Market Size and Forecast
  • 06.5. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Blood Glucose Testing Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Infectious Diseases Testing Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Cardiac Markers Testing Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global Coagulation Testing Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global Pregnancy and Fertility Testing Market
    • 07.5.1. Market Size and Forecast
  • 07.6. Global Blood Gas/Electrolytes Testing Market
    • 07.6.1. Market Size and Forecast
  • 07.7. Global Tumor Markers Testing Market
    • 07.7.1. Market Size and Forecast
  • 07.8. Global Urinalysis Testing Market
    • 07.8.1. Market Size and Forecast
  • 07.9. Global Cholesterol Testing Market
    • 07.9.1. Market Size and Forecast

08. Geographical Segmentation

  • 08.1. POC Diagnostics Market in Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. POC Diagnostics Market in EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. POC Diagnostics Market in APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2014
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Abbott Laboratories
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation by Revenue
    • 17.1.4. Business Segmentation by Revenue 2011 and 2012
    • 17.1.5. Geographical Segmentation by Revenue
    • 17.1.6. Business Strategy
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
  • 17.2. Alere
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation by Revenue 2013
    • 17.2.4. Business Segmentation by Revenue 2012 and 2013
    • 17.2.5. Geographical Segmentation by Revenue 2013
    • 17.2.6. Business Strategy
    • 17.2.7. Recent Developments
    • 17.2.8. SWOT Analysis
  • 17.3. Bayer HealthCare
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation by Revenue 2013
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Geographical Segmentation by Revenue 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Recent Developments
    • 17.3.8. SWOT Analysis
  • 17.4. Danaher
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Revenue by Business Segmentation
    • 17.4.5. Revenue Comparison 2012 and 2013
    • 17.4.6. Segmentation by Geography
    • 17.4.7. Business Strategy
    • 17.4.8. Key Information
    • 17.4.9. SWOT Analysis
  • 17.5. F. Hoffmann-La Roche
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation
    • 17.5.4. Geographical Segmentation by Revenue 2013
    • 17.5.5. Business Strategy
    • 17.5.6. Key Information
    • 17.5.7. SWOT Analysis
  • 17.6. Johnson & Johnson
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation by Revenue 2013
    • 17.6.4. Business Segmentation by Revenue 2012 and 2013
    • 17.6.5. Geographical Segmentation by Revenue 2013
    • 17.6.6. Business Strategy
    • 17.6.7. Recent Developments
    • 17.6.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global POC Diagnostics Market 2014-2019 (US$ million)
  • Exhibit 3: POC Diagnostics Market in US 2014-2019 (US$ million)
  • Exhibit 4: POC Diagnostics Market in Europe 2014-2019 (US$ million)
  • Exhibit 5: Segmentation of Global POC Diagnostics Market by Application
  • Exhibit 6: Global POC Diagnostics Market by Application 2014
  • Exhibit 7: Global Blood Glucose Testing Market 2014-2019 (US$ million)
  • Exhibit 8: Global Infectious Diseases Testing Market 2014-2019 (US$ million)
  • Exhibit 9: Global Cardiac Markers Testing Market 2014-2019 (US$ million)
  • Exhibit 10: Global Coagulation Testing Market 2014-2019 (US$ million)
  • Exhibit 11: Global Pregnancy and Fertility Testing Market 2014-2019 (US$ million)
  • Exhibit 12: Global Blood Gas/Electrolytes Testing Market 2014-2019 (US$ million)
  • Exhibit 13: Global Tumor Markers Testing Market 2014-2019 (US$ million)
  • Exhibit 14: Global Urinalysis Testing Market 2014-2019 (US$ million)
  • Exhibit 15: Global Cholesterol Testing Market 2014-2019 (US$ million)
  • Exhibit 16: Segmentation of Global POC Diagnostics Market by Application 2014-2019 (US$ million)
  • Exhibit 17: Segmentation of Global POC Diagnostics Market by Application 2014-2019
  • Exhibit 18: Geographical Segmentation of Global POC Diagnostics Market 2014
  • Exhibit 19: POC Diagnostics Market in Americas 2014-2019 (US$ million)
  • Exhibit 20: POC Diagnostics Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 21: POC Diagnostics Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 22: Geographical Segmentation of Global POC Diagnostics Market 2014-2019 (US$ million)
  • Exhibit 23: Geographical Segmentation of Global POC Diagnostics Market 2014-2019
  • Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 25: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 26: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 27: Global POC Diagnostics Market: Business Segmentation by Revenue 2013
  • Exhibit 28: Global POC Diagnostics Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 29: Global POC Diagnostics Market: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 31: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 32: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 33: Danaher: Business Segmentation
  • Exhibit 34: Danaher: Business Segmentation 2013
  • Exhibit 35: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 36: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 37: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 38: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 39: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
  • Exhibit 40: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
  • Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2013
  • Exhibit 42: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 43: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Back to Top